NR565 WK 6 Asthma 1
Asthma Treatment Algorithm:
To successfully treat asthma, you must first classify it and then be familiar with step therapy. For this assignment and in this course,
we will focus on patients 12 yea
...
NR565 WK 6 Asthma 1
Asthma Treatment Algorithm:
To successfully treat asthma, you must first classify it and then be familiar with step therapy. For this assignment and in this course,
we will focus on patients 12 years and older. Complete the blanks in the following table to create an algorithm for asthma care using
your textbook as well as GINA guidelines .
Step Asthma
Classificatio
n
Asthma symptoms and frequency as
noted in textbook
Controller and Preferred
Reliever:
(Drug Class and frequency if
provided from GINA guidelines)
Controller and Alternative
Reliever:
(Drug Class and frequency if
provided from GINA guidelines)
Step 1 Intermittent
Daytime
symptoms 2 d/wk or less
Drug class: Low dose ICSformoterol
Frequency: As-needed
Drug class: Take ICS
Nighttime Frequency: when SABA is taken
awakenings 2 times/month or less
Step 2 Mild Persistent
Daytime
symptoms
More than 2 d/wk but less
than daily
Drug class: Low dose maintence
ICS Nighttime
awakenings 3–4 times/month
Step 3 Moderate
Persistent
Daytime
symptoms Daily
Drug class:
Low dose maintenance ICSformoterol
Drug class: Low dose maintence
ICS-LABA Nighttime
awakenings
More than once/week but
less than nightly
Step
4-5
Severe
Persistent Daytime
symptoms Several time daily
Step 4:
Drug class: Medium dose
maintenance ICS-formoterol
Drug class: High/medium dose
ICS-LABA
Nighttime
awakenings
Often nightly Step 5:
Drug class: Add LAMA, &
consider high dose ICS-formoterol
Refer for: phenotypic assessment,
No change.
This study source was downloaded by 100000834091502 from CourseHero.com on 11-16-2022 19:28:03 GMT -06:00
NR565 WK 6 Asthma 2
+/- anti-IgE, anti-IL5/R5, anti-IL4R,
& consider high dose ICSformoterol
Starting treatment:
Complete this section using the GINA guidelines provided.
First Assess:
1. Confirm diagnosis
2. Symptom control
3. Modifiable risk factors
4. Comorbidities
5. Inhaler technique & adherance
6. Patient preference
[Show More]